The Community Guide

- gsearch

Search Results

Narrow Results:

2023 1
2021 1

HIV Outpatient Study (HOPS) Investigators 1

Journal Article 2

1 - 2 of 2 Results

Refine Results

Refine Results:

Disparities in Treatment with Direct-Acting Hepatitis C Virus Antivirals Persist Among Adults Coinfected with HIV and Hepatitis C Virus in US Clinics, 2010–2018

CITE Title : Disparities in Treatment with Direct-Acting Hepatitis C Virus Antivirals Persist Among Adults Coinfected with HIV and Hepatitis C Virus in US Clinics, 2010–2018 Personal Author(s) : Simoncini, Gina M.;Hou, Qingjiang;Carlson, Kimberly;Buchacz, Kate;Tedaldi, Ellen;Palella, Frank;Durham, Marcus;Li, Jun; Corporate Authors(s) : HIV Outpatient Study (HOPS) Investigators Published Date : 10 2021;10-2021; Source : AIDS Patient Care STDS. 35(10):392-400 URL : https://stacks.cdc.gov/view/cdc/153447 Simoncini, Gina M. et al. (2021). Disparities in Treatment with Direct-Acting Hepatitis C Virus Antivirals Persist Among Adults Coinfected with HIV and Hepatitis C Virus in US Clinics, 2010–2018. 35(10). Simoncini, Gina M. et al. "Disparities in Treatment with Direct-Acting Hepatitis C Virus Antivirals Persist Among Adults Coinfected with HIV and Hepatitis C Virus in US Clinics, 2010–2018" 35, no. 10 (2021) Simoncini, Gina M. et al. "Disparities in Treatment with Direct-Acting Hepatitis C Virus Antivirals Persist Among Adults Coinfected with HIV and Hepatitis C Virus in US Clinics, 2010–2018" vol. 35, no. 10, 2021 Export RIS Citation Information.

:

Simoncini, Gina M.

;

Hou, Qingjiang

10 2021 | AIDS Patient Care STDS. 35(10):392-400

:

Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) coinfection carries substantial risk for all-cause mortality and liver-related morbidit...
Weight gain and metabolic effects in persons with HIV who switch to ART regimens containing integrase inhibitors or tenofovir alafenamide

CITE Title : Weight gain and metabolic effects in persons with HIV who switch to ART regimens containing integrase inhibitors or tenofovir alafenamide Personal Author(s) : Palella, Frank J.;Hou, Qingjiang;Li, Jun;Mahnken, Jonathan;Carlson, Kimberly J.;Durham, Marcus;Ward, Douglas;Fuhrer, Jack;Tedaldi, Ellen;Novak, Richard;Buchacz, Kate; Published Date : 1 01 2023;1-01-; Source : J Acquir Immune Defic Syndr. 92(1):67-75 URL : https://stacks.cdc.gov/view/cdc/175439 Palella, Frank J. et al. (2023). Weight gain and metabolic effects in persons with HIV who switch to ART regimens containing integrase inhibitors or tenofovir alafenamide. 92(1). Palella, Frank J. et al. "Weight gain and metabolic effects in persons with HIV who switch to ART regimens containing integrase inhibitors or tenofovir alafenamide" 92, no. 1 (2023) Palella, Frank J. et al. "Weight gain and metabolic effects in persons with HIV who switch to ART regimens containing integrase inhibitors or tenofovir alafenamide" vol. 92, no. 1, 2023 Export RIS Citation Information.

:

Palella, Frank J. ;

Hou, Qingjiang

1 01 2023 | J Acquir Immune Defic Syndr. 92(1):67-75

:

Background:The timing and magnitude of antiretroviral therapy-associated weight change attributions are unclear.Setting:HIV Outpatient Study participa...